# SEG Internship Duplicate File-Level Comparison Preparation

**Phase:** 7.4 — Controlled Governance Gate Closure  
**Mode:** `READ_ONLY GOVERNANCE CLOSURE EXECUTION`  
**Date recorded:** `2026-08-18`  
**Processing state:** `COMPARISON_PREPARED — ATTRIBUTABLE DUPLICATE REVIEW OPEN`

## 1. Purpose and non-selection boundary

This report prepares a file-level comparison of `DUP-DRUG-001` and `DUP-EMERGENCY-001`. It compares preserved Base and `v2_Pack` lineages using exact paths, SHA-256 values, byte/line counts, heading structure, observable coverage cues, and source-side implementation evidence. It does not determine clinical equivalence, approve content, select a canonical production source, delete, archive, merge, overwrite, rename, or replace any file.[1] [2]

The labels **Base** and **v2_Pack** identify preserved comparison groups only. They are not production roles. Earlier design-level recommendations remain non-canonical and do not replace this file-level comparison evidence.[3]

## 2. Exact files and fingerprints

### 2.1 `DUP-DRUG-001`

| Comparison group | Source ID | Preserved path | SHA-256 | Bytes | Lines | Headings | Bullet lines |
|---|---|---|---|---:|---:|---:|---:|
| Base | `SRC-0023` | `02_Internship/Drug_Essentials/drug_essentials_intern_level_v2.md` | `bb0508f5b5a4bbdbf4919d28f4115f444c26ed514c2c4f50f13723bab91225fb` | 13,847 | 443 | 41 | 144 |
| Base | `SRC-0024` | `02_Internship/Drug_Essentials/implementation_notes.md` | `810d08ed40ef7f190995b2eead2d8ee670d06de511223e1455dea5bb3d9d1e1e` | 1,237 | 55 | 5 | 25 |
| Base | `SRC-0025` | `02_Internship/Drug_Essentials/README.txt` | `64469d1134e1045a96230469388ea31b7f4adc797be7f2260696df30a0e93401` | 616 | 21 | 0 | 3 |
| v2_Pack | `SRC-0027` | `02_Internship/Drug_Essentials_v2_Pack/drug_essentials_intern_level_v2.md` | `2bc084ccf0d074cf22573b8ca352b0918eb1ca448eed8f2a6885a3f5e2777d27` | 13,437 | 442 | 42 | 144 |
| v2_Pack | `SRC-0028` | `02_Internship/Drug_Essentials_v2_Pack/implementation_notes.md` | `5a30d419e6aa14626652532d3d657a7657f4cea2dc49980805497d29d5a36831` | 1,212 | 54 | 6 | 25 |
| v2_Pack | `SRC-0029` | `02_Internship/Drug_Essentials_v2_Pack/README.txt` | `5c2377e8c30aa6c901eb5bb5a3b4c6679c33f27de883c480a42e38eab6282eb5` | 626 | 20 | 0 | 3 |

### 2.2 `DUP-EMERGENCY-001`

| Comparison group | Source ID | Preserved path | SHA-256 | Bytes | Lines | Headings | Bullet lines |
|---|---|---|---|---:|---:|---:|---:|
| Base | `SRC-0033` | `02_Internship/Emergency_Cases/emergency_cases_intern_level.md` | `2b3afae2bf4d19d837f0075ca979c5810d49eb3e82f0dcb9356ce1a47962a99c` | 17,880 | 737 | 81 | 335 |
| Base | `SRC-0034` | `02_Internship/Emergency_Cases/implementation_notes.md` | `6b74fe4e4b450289df6cb54358f32f46da737236646310da9784d5cefde649a8` | 1,414 | 63 | 5 | 31 |
| Base | `SRC-0035` | `02_Internship/Emergency_Cases/README.txt` | `e22eeb24f6ed69e75ae1d4d6c90e4ce67a4b0549a2c7af5364e578011e8a17bd` | 566 | 21 | 0 | 3 |
| v2_Pack | `SRC-0037` | `02_Internship/Emergency_Cases_v2_Pack/emergency_cases_intern_level.md` | `455983813a4f540fc6b5f9520e245886ed775c1ae472ade79ce7089b6ed068a4` | 17,420 | 736 | 82 | 335 |
| v2_Pack | `SRC-0038` | `02_Internship/Emergency_Cases_v2_Pack/implementation_notes.md` | `4fedbe459e19e938cb63fb164d025e651593d0b7dc56a75237d05c8fd83d3495` | 1,389 | 62 | 6 | 31 |
| v2_Pack | `SRC-0039` | `02_Internship/Emergency_Cases_v2_Pack/README.txt` | `81d8a30163db1bc453c936dc9815a42630acebd88f48905d4befb44b626c0ce1` | 576 | 20 | 0 | 3 |

The SHA-256 differences confirm that the paired files are not byte-identical. The measurements below describe observable structure and coverage cues only; they do not establish semantic equivalence or clinical correctness.

## 3. Structure comparison

| Family | Base-to-v2_Pack structural observation | Evidence interpretation |
|---|---|---|
| `DUP-DRUG-001` | The main Markdown files have 443 versus 442 lines, 41 versus 42 headings, and equal bullet-line counts of 144. The v2_Pack main file contains an additional title-level heading in the observed heading outline. Implementation notes have 55 versus 54 lines and 5 versus 6 headings; README files have 21 versus 20 lines and no headings in either group. | The paired directory layouts preserve mirrored logical roles, but the files are not structurally identical at byte/line/heading level. |
| `DUP-EMERGENCY-001` | The main Markdown files have 737 versus 736 lines, 81 versus 82 headings, and equal bullet-line counts of 335. The v2_Pack main file contains an additional title-level heading in the observed heading outline. Implementation notes have 63 versus 62 lines and 5 versus 6 headings; README files have 21 versus 20 lines and no headings in either group. | The paired directory layouts preserve mirrored logical roles, but the files are not structurally identical at byte/line/heading level. |

## 4. Coverage comparison

### 4.1 Drug Essentials

The Base and `v2_Pack` main files share the observed topical outline from the medication-safety purpose and 30-second pause through high-risk drug groups, intern boundaries, confirmation workflow, monitoring, documentation, JMC/exam traps, checklist, future-level notes, implementation notes, and source-use note. The high-risk-group and exam-trap headings are present in both measured outlines. Equal bullet-line counts support comparable outline density, while the different hashes, byte counts, line counts, and heading count show that coverage cannot be treated as identical without an attributable content comparison.

The paired implementation notes both carry safety boundaries against adding doses, infusion/drip rates, RSI or antidote dosing, local protocols, and copied questions, and both identify conceptual source bases rather than permission to copy copyrighted wording or questions.[4] [5] These are source-side boundaries, not rights clearance or medical approval.

### 4.2 Emergency Cases

The Base and `v2_Pack` main files share ten observed case headings: Chest Pain; Shortness of Breath; Altered Mental Status; Abdominal Pain; Fever / Sepsis Concern; Trauma; Seizure; Anaphylaxis / Severe Allergic Reaction; Pediatric Fever / Dehydration; and Overdose / Unknown Ingestion. They also share repeated case-section headings for presentation, what the intern should notice, immediate thinking, calling a senior early, JMC/exam traps, and handover lines. Equal bullet-line counts support comparable outline density, while different hashes, byte counts, line counts, and heading counts prevent a conclusion of identical coverage without review.

The paired implementation notes both state an expected educational case structure and safety boundaries against medication doses, administration instructions, local protocols, fixed triage times, definitive disposition rules, and copied questions. They also identify the same conceptual source bases and no-copy boundary.[6] [7] These statements do not provide a license, publication permission, or clinical sign-off.

## 5. Evidence-difference comparison

| Evidence dimension | Base lineage | v2_Pack lineage | Closure result |
|---|---|---|---|
| Directory/path identity | Base directories `Drug_Essentials/` and `Emergency_Cases/` | Separate `Drug_Essentials_v2_Pack/` and `Emergency_Cases_v2_Pack/` directories | Distinct preserved paths; no merge authorized. |
| File fingerprint | Each paired file has a distinct SHA-256 | Each paired file has a distinct SHA-256 | File-level difference confirmed. |
| Logical role | Main content, implementation notes, README | Mirrored main content, implementation notes, README | Role mirroring observed; not proof of equivalence. |
| Source basis | Implementation notes identify conceptual source-informed use and no-copy boundary | Same source-basis pattern and no-copy boundary | Partial source-use evidence only; no external licensing asserted. |
| Safety boundary | Medication/case safety restrictions are recorded in source-side notes | Same category of restrictions is recorded in source-side notes | Boundary evidence is preserved; it is not a rights or clinical gate closure. |
| Owner/publisher | Not supplied in the compared file set | Not supplied in the compared file set | `OPEN` |
| Governed version | Not supplied; `v2` in a path/name is not treated as governed version | Not supplied; `v2` in a path/name is not treated as governed version | `OPEN` |
| Text/image/PDF/display rights | No package-specific closure in the compared file set | No package-specific closure in the compared file set | `OPEN` |
| Attributable reviewer decision | Not supplied at per-file comparison level | Not supplied at per-file comparison level | `OPEN` |
| Track/taxonomy | Internship folder/context is not per-file proof of `02_Internship` or taxonomy ID/version | Same limitation | `OPEN` |
| Clinical equivalence | Not assessed | Not assessed | `OPEN` |

## 6. Required attributable review before any future decision

A separately authorized reviewer must compare the paired files at exact body/section/table/locator level, record the actor and role, state the comparison method, preserve both hashes, document owner/version/rights/reviewer/track/taxonomy/audit evidence, and record any unresolved difference. The review must not turn a comparison role into a canonical production selection. Any future source decision must preserve rollback and lineage traceability.

## 7. Comparison decision state

| Family | Preparation result | Production/canonical state |
|---|---|---|
| `DUP-DRUG-001` | `FILE_LEVEL_COMPARISON_PREPARED — STRUCTURAL/COVERAGE CUES RECORDED` | `NO CANONICAL PRODUCTION SOURCE SELECTED` |
| `DUP-EMERGENCY-001` | `FILE_LEVEL_COMPARISON_PREPARED — STRUCTURAL/COVERAGE CUES RECORDED` | `NO CANONICAL PRODUCTION SOURCE SELECTED` |

The duplicate gate remains `OPEN` pending an attributable comparison decision and the other independent governance gates. No deletion, archive, merge, overwrite, rename, or replacement is permitted by this preparation package.

## 8. Validation and non-actions

The comparison was performed read-only against preserved staging files and carried-forward manifest evidence. No source was edited. No JSON was generated, no schema was converted or revalidated, no import occurred, and no database or application was modified. No content was activated or published.

## References

[1]: /home/ubuntu/seg-internship-output/SEG_INTERNSHIP_REVALIDATION_ARTIFACT_MANIFEST.md "Phase 7.0 Revalidation Artifact Manifest"
[2]: /home/ubuntu/seg-internship-output/SEG_INTERNSHIP_FINAL_LINEAGE_CROSSWALK.md "Phase 6.4 Final Lineage Crosswalk"
[3]: /home/ubuntu/seg-internship-output/SEG_INTERNSHIP_DUPLICATE_FINALIZATION_REPORT.md "Phase 6.4 Duplicate Finalization Report"
[4]: /home/ubuntu/seg-internship-phase-5.6/staging/extracted/02_Internship/Drug_Essentials/implementation_notes.md "Drug Essentials Base implementation notes"
[5]: /home/ubuntu/seg-internship-phase-5.6/staging/extracted/02_Internship/Drug_Essentials_v2_Pack/implementation_notes.md "Drug Essentials v2_Pack implementation notes"
[6]: /home/ubuntu/seg-internship-phase-5.6/staging/extracted/02_Internship/Emergency_Cases/implementation_notes.md "Emergency Cases Base implementation notes"
[7]: /home/ubuntu/seg-internship-phase-5.6/staging/extracted/02_Internship/Emergency_Cases_v2_Pack/implementation_notes.md "Emergency Cases v2_Pack implementation notes"
[8]: /home/ubuntu/seg-internship-output/SEG_INTERNSHIP_AUDIT_EVIDENCE_PREPARATION.md "Phase 7.4 Audit Evidence Preparation"

<!-- END OF REPORT -->
